来源:[1] 独家:美国FDA高层内部推动加快礼来减肥药裁决 - 路透社 (https://www.reuters.com/sustainability/boards ...)[2] FDA官僚机构的缺失正在自毁药企前景 - BioSpace (https://www.biospace.com/policy/absence-of-bu ...)[3] FDA批准USAntibiotics’ Augmentin XR,开创快速审查项目先河 - BioSpace (https://www.biospace.com/press-releases/fda-a ...)